Free Trial
Thank you for registering! Take a moment to confirm your subscription to MarketBeat Daily Ratings so that you can access MarketBeat's tools, reports, and news. Please click the "Send Confirmation Email" button and we'll send you an email with confirmation instructions.

ORIC Pharmaceuticals (ORIC) SEC Filings & 10K Form

$8.99
+0.06 (+0.67%)
(As of 05/31/2024 ET)

Recent ORIC Pharmaceuticals SEC Filings

DateFilerForm TypeView
04/24/2024
3:15 PM
ORIC Pharmaceuticals (Filer)
Form ARS
04/24/2024
3:06 PM
ORIC Pharmaceuticals (Filer)
Form DEF 14A
04/24/2024
3:10 PM
ORIC Pharmaceuticals (Filer)
Form DEFA14A
03/29/2024
3:47 PM
ORIC Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/29/2024
3:15 PM
ORIC Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/11/2024
4:28 PM
ORIC Pharmaceuticals (Filer)
Form S-3ASR
03/11/2024
3:20 PM
ORIC Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
[Urgent!] Generational Wealth Gameplan (Ad)

A brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan that could help you retire quickly and comfortably in today's crypto market.

Click here to get instant access to the guide
03/11/2024
7:19 AM
FMR LLC (Filed by)
ORIC Pharmaceuticals (Subject)
Form SC 13G/A
03/08/2024
3:20 PM
Chacko Jacob (Reporting)
ORIC Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
5:19 PM
EcoR1 Capital, LLC (Filed by)
ORIC Pharmaceuticals (Subject)
Form SC 13G/A
02/13/2024
5:43 PM
ALKEON CAPITAL MANAGEMENT LLC (Filed by)
ORIC Pharmaceuticals (Subject)
Form SC 13G/A
02/13/2024
8:26 AM
ORIC Pharmaceuticals (Subject)
Prosight Management, LP (Filed by)
Form SC 13G/A
02/09/2024
8:28 AM
FMR LLC (Filed by)
ORIC Pharmaceuticals (Subject)
Form SC 13G/A
02/08/2024
7:01 PM
Chacko Jacob (Reporting)
ORIC Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/07/2024
4:09 PM
BlackRock Inc. (Filed by)
ORIC Pharmaceuticals (Subject)
Form SC 13G/A
02/04/2024
11:15 PM
ORIC Pharmaceuticals (Filer)
Form EFFECT
01/30/2024
11:12 AM
ORIC Pharmaceuticals (Filer)
Form D
Notice of Exempt Offering of Securities 
01/29/2024
4:25 PM
BlackRock Inc. (Filed by)
ORIC Pharmaceuticals (Subject)
Form SC 13G
01/22/2024
8:01 AM
ORIC Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/09/2024
8:00 AM
ORIC Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/28/2023
11:15 PM
ORIC Pharmaceuticals (Filer)
Form EFFECT
12/19/2023
6:40 PM
ORIC Pharmaceuticals (Issuer)
Piscitelli Dominic (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/19/2023
6:42 PM
Multani Pratik S (Reporting)
ORIC Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/19/2023
6:39 PM
Chacko Jacob (Reporting)
ORIC Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/15/2023
3:32 PM
ORIC Pharmaceuticals (Filer)
Form S-3
Registration statement under Securities Act of 1933  
11/06/2023
3:20 PM
ORIC Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/06/2023
3:10 PM
ORIC Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/23/2023
3:07 PM
ORIC Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/11/2023
8:28 PM
Chacko Jacob (Reporting)
ORIC Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/07/2023
3:15 PM
Nextech Crossover I GP S.a r.l. (Filed by)
ORIC Pharmaceuticals (Subject)
Form SC 13G
07/05/2023
2:27 PM
ORIC Pharmaceuticals (Filer)
Form D
Notice of Exempt Offering of Securities 
06/28/2023
6:18 PM
Chacko Jacob (Reporting)
ORIC Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2023
5:05 AM
ORIC Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/26/2023
5:25 PM
Chacko Jacob (Reporting)
ORIC Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:ORIC) was last updated on 6/1/2024 by MarketBeat.com Staff

From Our Partners